Long-term safety, efficacy and pharmacokinetics of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) monoclonal antibody SHP647 in crohn's disease: The opera II study

Authors
Category Primary study
JournalInflammatory bowel diseases
Year 2019
This article has no abstract
Epistemonikos ID: a5a7f50c2a4f2c8b175dee1d15463093e98854ca
First added on: Feb 01, 2023